TABLE 4.
Distribution of IGQ scores among GP subjects and IBS patients
| Total (n = 305) | Total (n = 305)* | GPop (n = 119)** | IBS (n = 186)*** | p‐Valuea |
|---|---|---|---|---|
| Global score (GS) | 37.17 ± 15.87 | 33.47 ± 16.92 | 39.54 ± 14.72 | 0.0016 |
| Global score (except BL) | 35.60 ± 16.44 | 33.10 ± 17.54 | 37.20 ± 15.54 | 0.0385 |
| Bloating (BL) | 44.76 ± 23.91 | 35.17 ± 23.70 | 50.87 ± 22.02 | p < 0.0001 |
| Flatulence (FL) | 50.02 ± 24.98 | 45.67 ± 26.73 | 52.80 ± 23.43 | 0.018 |
| Belching (BE) | 32.85 ± 30.05 | 33.26 ± 31.54 | 32.58 ± 29.13 | 0.85 |
| Bad breath (BB) | 25.92 ± 25.61 | 28.34 ± 26.02 | 24.36 ± 25.29 | 0.19 |
| Stomach rumbling (SR) | 32.97 ± 26.39 | 28.80 ± 28.44 | 35.63 ± 24.71 | 0.0325 |
| Difficult gas evacuation (DGE) | 36.43 ± 25.87 | 29.41 ± 25.55 | 40.93 ± 25.12 | 0.0001 |
Scores range from 0‐100 (worst symptom or impact). Due to a few missing data, the number of patients analyzed varies depending of the dimension scores: *n = 302‐305, **n = 118‐119, ***n = 184‐186.
Abbreviations: GPop, General Population; IBS, Irritable Bowel Syndrome.
a
Comparison between GPop and IBS (t‐test).